Contact
Please use this form to send email to PR contact of this press release:
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies
TO:
Please use this form to send email to PR contact of this press release:
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies
TO: